Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516265 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard Copy (Hard Back)Add to Basket
Electronic (PDF)Add to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

The Future of Parenteral Nutrition: Key Players, Disease Specific Opportunities and Market Forecasts

Business Insights, Oct 2010, Pages: 117


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

In 2009, approximately 390,000 patients in the major markets of the US, EU and Canada used parenteral nutrition products, accounting for total product sales of $1.3b. Through 2014, the total number of parenteral nutrition users in will rise by 10.0% per year to 628,000 and sales will expand by 11.3% per year, reflecting only nominal annual price increases. Four manufacturers currently jockey for share in this closely held market: market leader Baxter, enteral and parenteral products suppliers Fresenius Kabi and B. Braun, and Hospira. Although the introduction of new parenteral solutions is infrequent, these four players are differentiating themselves through hardware improvements, expanded pediatric labeling, new product formats and enhanced systems and services for home use. This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled ?US, Canada and EU ?it investigates near and long term opportunities as well as recent product launches. Finally, it summarizes these opportunities in the context of product development initiatives currently underway at the leading manufacturers.

This report investigates these market opportunities, as well as emerging product development trend such as combination products and products developed for specialized disease populations. In each region profiled – US, Canada and EU – it investigates near and long term opportunities as well as recent product launches. rbcn0013

Scope of this research

- Develop deeper insight into the size and growth of the US, Canadian and EU parenteral nutrition industry, as well as individual EU country markets.

- Understand key product development trends in the parenteral nutrition market and the R&D strategies of the major players.

- Identify short and long term market opportunities in each region.

- Anticipate future parenteral nutrition market needs in light of the drivers and restraints acting upon the market.

- Describes the major market drivers and restraints in the US, Canada and EU, with detail provided for Germany, France, UK, Italy, Spain & Poland

Research and analysis highlights

Growth will be driven by increasing usage as the populations in these regions continue to age and incidence of conditions associated with parenteral nutrition, such as cancer and gastrointestinal disease, rises.

The total US, Canadian and EU parenteral nutrition market reached $1.3b in 2009 and is growing by 11.3% per year to reach $2.3bn in 2014. In 2009, Baxter led the market with 29.5% share, followed by Fresenius Kabi with 28.7%, B. Braun Melsungen with 22.2% and Hospira with 16.9%.

Major near term opportunities for new products include improved hardware and accessories, and products developed for home use. Important new recent launches include the triple-chamber bag, which three of the top four manufacturers now offer.

Key reasons to purchase this research

- What are the regional differences between the parenteral markets in the US, Canada, Germany, France, UK, Italy, Spain and Poland?

- Which companies are current and future key players and what are the issues driving new product development?

- What is limiting greater parenteral nutrition usage and how are prescribing decisions made by clinicians?

- What emerging products could significantly impact parenteral nutrition sales & what new product initiatives are being pursued by the leading players?

- What will the size and growth of the global parenteral nutrition market be through 2014?



Customers who bought this item also bought

Clinical Nutrition Pricing and Reimbursement Trends in North America and Europe

Opportunities in Malnutrition Management

Clinical Nutrition Products - Global Strategic Business Report

Opportunities in Nutritional Management: Food and Drinks to Aid Disease Recovery

The World Protein Ingredient Market

Animal Feed Additives - Global Strategic Business Report

Agriculture - Global Outlook

Gelatin - Global Strategic Business Report

Nutraceuticals - Global Strategic Business Report

The Future of Nutrition Labeling for Food and Drinks in Europe: Evolving Consumer Needs, Manufacturer and Retailer Strategies and Market Opportunities



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds